Raul G. Nogueira

Advisor at Anaconda BioMed

Dr. Nogueira completed his Neurology Residency at the Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital/ Harvard Medical School in 2002. He subsequently completed Fellowships in Vascular and Critical Care Neurology as well as Neurointerventional Surgery at the MGH where he remained as a faculty member for five additional years. He moved to Atlanta in September 2010 to help building the Marcus Stroke & Neuroscience Center at the Grady Memorial Hospital where he serves as the Director of the Neuroendovascular Service. He is a Professor of Neurology, Neurosurgery and Radiology at the Emory University School of Medicine, the Editor-in-Chief for the Interventional Neurology Journal and the Immediate Past President of the Society of Vascular and Interventional Neurology (SVIN). He has been involved in many of the mechanical thrombectomy trials for acute stroke. He was the Principal Investigator of the DAWN, Penumbra 3D Separator, and TREVO-2 trials and a Steering Committee member for the SWIFT, SWIFT Prime, and ARISE-II trials. He is currently the Principal Investigator for the RESILIENT and ENDOLOW trials. He has published over 250 manuscripts in peer-reviewed medical journal including NEJM, the Lancet, JAMA, Neurology, Stroke, AJNR, JAMA Neurology, and Circulation amongst others. He specializes in the treatment of cerebrovascular diseases including ischemic stroke, brain aneurysm, cerebral and spinal vascular malformations, and intracranial and extracranial stenosis.